Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial.
about
Pleiotropic effects of statinsKnowledge and perception about stroke among an Australian urban populationCholesterol as a Risk Factor for Subarachnoid Hemorrhage: A Systematic ReviewManagement of intracerebral hemorrhage--use of statinsArachidonic Acid and Cerebral Ischemia Risk: A Systematic Review of Observational StudiesEgg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studiesShared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variantsAssociation between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort ConsortiumStroke prevention in diabetes and obesityEfficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trialsStroke Risk Factors, Genetics, and Prevention.Trans-sodium crocetinate provides neuroprotection against cerebral ischemia and reperfusion in obese mice.Clinical factors associated with statins prescription in acute ischemic stroke patients: findings from the Lombardia Stroke RegistryHistone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism.Low cholesterol level associated with severity and outcome of spontaneous intracerebral hemorrhage: Results from Taiwan Stroke RegistrySex Differences in the Clinical Features, Risk Factors, and Outcomes of Intracerebral Hemorrhage: a Large Hospital-based Stroke Registry in ChinaAcute ischemic stroke therapy.Lipid profiles and ischemic stroke risk: variations by sex within racial/ethnic groups.Program of rehabilitative exercise and education to avert vascular events after non-disabling stroke or transient ischemic attack (PREVENT Trial): a multi-centred, randomised controlled trialEffect of lipid profile upon prognosis in ischemic and haemorrhagic cerebrovascular stroke.Atorvastatin in stroke: a review of SPARCL and subgroup analysis.Statins and cerebrovascular disease: plaque attack to prevent brain attack.Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke.Statins and cardiovascular diseases: from cholesterol lowering to pleiotropyLipoprotein (a) and strokeIs the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study.Dynamic temporal change of cerebral microbleeds: long-term follow-up MRI study.Egg consumption and carotid atherosclerosis in the Northern Manhattan study.Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protectionStroke: epidemiology, clinical picture, and risk factors--Part I of III.Primary stroke prevention.Treatment of the elderly with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors: focus on drug interactions.Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort studyIncreased stroke risk and lipoprotein(a) in a multiethnic community: the Northern Manhattan Stroke Study.HMG coenzyme A reductase inhibitors: good news and bad news.Doppler study of cerebral arteries in hypercholesterolemiaHypolipidemia: a word of cautionHypolipemic agents for stroke prevention.Gender differences in the prevalence and development of metabolic syndrome in Chinese population with abdominal obesityMortality, cardiovascular risk factors, and diet in China, Finland, and the United States.
P2860
Q24647863-9FFFE9E1-F3EA-44AD-BA18-972C7ABC5F57Q24796154-4A207660-5635-41D0-B1D4-3463D9A35B7DQ26748320-852D8D52-9BF1-49B6-97B4-9C2950D80538Q26752952-14945898-1813-440F-945C-C9041A8BB40CQ26801643-F21E8D9F-6703-4DEA-98E1-585701927949Q26823037-E80BC3D4-3081-4F69-97D9-FE750C32AAA8Q27008212-B1E24FCA-9E48-487E-AABC-2A11DEE9EAF5Q27022672-D1CD2B22-168E-46E5-A380-C6C42E971EB6Q28200179-ECEB71AD-8B9C-4128-A1D1-8B836B421AA7Q29617910-BD2F885A-A270-4B96-B1BA-785D41A8FF81Q30238633-72A68571-C080-4CCD-9212-FE64918AC79EQ30301142-88172A4B-BDC3-40C1-A74D-0AA82C77954AQ31154390-70572FB0-E8FE-44AB-B998-7677FE41EFD7Q33380457-CAA5EF76-1BB9-44FF-B11D-EBA7983A8391Q33579357-388E264E-B5A8-4687-A6F7-FB2836D4BF13Q33671008-10E5BCCD-803F-4521-B722-8AE87CBB789CQ33714948-84EA4523-4570-4735-92B4-F74667AD992FQ33734445-5CFB1AEC-55D3-4347-8D07-D8A615B2D158Q33766889-427BA183-9C10-446C-B1BE-477AF27F230EQ33774559-413A381E-D6FC-4335-83B4-EA3304E4BDDDQ33797634-E287103C-94CF-4FA9-916A-01D3BC773647Q33805146-6F1CD8CF-F65C-4B32-88C7-7B636C114DD0Q33815841-17D828A6-49A9-43AC-AD98-A340F011F23AQ33960556-B2F6E6A3-880D-44D2-8DC8-88086EE1F1C4Q34015050-5B98AAA6-1C1F-42D8-A052-455B42943C5CQ34032851-DE97A1D8-B670-45B4-ACDB-4D1BBBB35610Q34055814-DE1C9189-73FC-469D-B5AE-92B53E152AD2Q34060266-912E1806-65AA-4FCD-B2A1-B52FA803A64BQ34088803-DFE95924-BCB9-49AF-BDF9-78808BFEA990Q34099742-45055B7F-0267-4253-8843-13D68363C229Q34339048-029B96B3-0EF6-47F4-8B45-89E012366D77Q34389584-EDA4A2D3-6DBF-4A12-BE13-2770A18443D9Q34715420-C7D8306B-4A81-42D4-8B36-67BFA329853DQ34724879-7F4AAAA9-41CE-4EDF-8C91-D48EFDBA25E6Q34751061-518FD4B3-5D92-424D-AAEB-30C9E25F800DQ34772929-6F4DC6D5-848A-4709-90D3-41CFEC73E394Q34780093-EB402CE8-041B-4727-AA7E-1DE9DF43D9B0Q35008533-BEF38AF7-66D4-4BFC-8B7A-BBEC0BF3D74BQ35032518-7F1BA7D1-E65D-4CDA-8472-399D432CDCEBQ35055175-161D7946-777E-44A1-809A-1D5EBC14D63A
P2860
Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial.
description
1989 nî lūn-bûn
@nan
1989 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Serum cholesterol levels and s ...... isk factor intervention trial.
@ast
Serum cholesterol levels and s ...... isk factor intervention trial.
@en
Serum cholesterol levels and s ...... isk factor intervention trial.
@nl
type
label
Serum cholesterol levels and s ...... isk factor intervention trial.
@ast
Serum cholesterol levels and s ...... isk factor intervention trial.
@en
Serum cholesterol levels and s ...... isk factor intervention trial.
@nl
prefLabel
Serum cholesterol levels and s ...... isk factor intervention trial.
@ast
Serum cholesterol levels and s ...... isk factor intervention trial.
@en
Serum cholesterol levels and s ...... isk factor intervention trial.
@nl
P2093
P1476
Serum cholesterol levels and s ...... isk factor intervention trial.
@en
P2093
P304
P356
10.1056/NEJM198904063201405
P407
P577
1989-04-01T00:00:00Z